CorMedix Inc. SEC filings CRMD

CorMedix Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 24, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

CorMedix Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2026 Nov 2, 2026
8-K Current report
Regulation FD disclosure
Oct 19, 2026 Oct 19, 2026
4 Insider transaction Sep 18, 2026 Sep 18, 2026
4 Insider transaction Sep 1, 2026 Aug 29, 2026
4 Insider transaction Sep 1, 2026 Aug 29, 2026
4 Insider transaction Sep 1, 2026 Aug 29, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Other events
Aug 7, 2026 Aug 7, 2026
8-K Current report
Other events
Jul 2, 2026 Jun 29, 2026
8-K Current report
Auditor change
Jul 1, 2026 Jun 25, 2026
S-8 POS Filing Jun 25, 2026 —
8-K Current report
Shareholder vote results
Jun 24, 2026 Jun 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 12, 2026 —
8-K Current report
Regulation FD disclosure
Jun 8, 2026 Jun 8, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 23, 2026
8-K Current report
Regulation FD disclosure
Apr 27, 2026 Apr 27, 2026
PRE 14A Preliminary proxy statement Apr 17, 2026 Apr 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
8-K Current report
Regulation FD disclosure
Mar 6, 2026 Mar 6, 2026
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 22, 2026 Jan 21, 2026
144 Notice of proposed sale Jan 21, 2026 —
4 Insider transaction Jan 20, 2026 Jan 12, 2026
4 Insider transaction Jan 20, 2026 Jan 12, 2026
4 Insider transaction Jan 15, 2026 Jan 8, 2026
3 Initial insider ownership Jan 15, 2026 Jan 8, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
8-K Current report
Results of operations, Officer or director change, Other events
Jan 8, 2026 Jan 5, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Dec 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 2, 2026 —
144 Notice of proposed sale Dec 30, 2025 —
4 Insider transaction Dec 19, 2025 Dec 18, 2025
144 Notice of proposed sale Dec 18, 2025 —
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 10, 2025 Dec 9, 2025
144 Notice of proposed sale Dec 9, 2025 —
144 Notice of proposed sale Dec 9, 2025 —
4 Insider transaction Dec 4, 2025 Dec 2, 2025
SCHEDULE 13G Ownership over 5% (passive) Dec 1, 2025 —
4 Insider transaction Nov 26, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 24, 2025 —
4 Insider transaction Nov 18, 2025 Nov 14, 2025
144 Notice of proposed sale Nov 14, 2025 —
S-8 Employee stock plan registration Nov 13, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
144 Notice of proposed sale Nov 10, 2025 —
144 Notice of proposed sale Nov 6, 2025 —
4 Insider transaction Oct 27, 2025 Oct 23, 2025
DEF 14A Proxy statement Oct 24, 2025 Nov 10, 2025
8-K Current report
Results of operations
Oct 20, 2025 Oct 20, 2025
PRER14A Proxy statement Oct 14, 2025 —
S-3ASR Automatic shelf registration Oct 7, 2025 —
RW Withdrawal request Oct 7, 2025 —
S-3ASR Automatic shelf registration Oct 6, 2025 —
RW Registration withdrawal request Oct 6, 2025 —
S-3 Shelf registration Sep 30, 2025 —
8-K/A Amended current report Sep 30, 2025 Aug 29, 2025
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
PRE 14A Preliminary proxy statement Sep 15, 2025 Sep 15, 2025
4 Insider transaction Sep 12, 2025 Sep 12, 2025
4 Insider transaction Sep 12, 2025 May 10, 2025
3 Initial insider ownership Sep 12, 2025 Sep 7, 2025
SCHEDULE 13D Ownership over 5% (active) Sep 12, 2025 —
144 Notice of proposed sale Sep 12, 2025 —
144 Notice of proposed sale Sep 12, 2025 —
4 Insider transaction Sep 11, 2025 Sep 9, 2025
4 Insider transaction Sep 11, 2025 Sep 9, 2025
144 Notice of proposed sale Sep 9, 2025 —
144 Notice of proposed sale Sep 9, 2025 —
4/A Filing Sep 8, 2025 Aug 29, 2025
4/A Filing Sep 8, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
3 Initial insider ownership Sep 3, 2025 Aug 29, 2025
144 Notice of proposed sale Sep 3, 2025 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
Sep 2, 2025 Aug 28, 2025
8-K Current report
Material agreement, Unregistered share sale
Aug 12, 2025 Aug 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 8, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
Aug 7, 2025 Aug 6, 2025
8-K Current report
Other events
Jun 30, 2025 Jun 26, 2025
424B5 Prospectus supplement Jun 30, 2025 —
424B5 Prospectus supplement Jun 26, 2025 —
8-K Current report
Shareholder vote results
Jun 25, 2025 Jun 24, 2025
8-K Current report
Regulation FD disclosure
Jun 23, 2025 Jun 23, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 24, 2025
8-K Current report
Auditor change
Apr 22, 2025 Apr 17, 2025
8-K Current report
Results of operations
Apr 8, 2025 Apr 8, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 4, 2025 —
4 Insider transaction Apr 3, 2025 Apr 2, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
10-K Annual report Mar 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 25, 2025 Mar 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
8-K Current report
Results of operations
Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4/A Filing Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 16, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Oct 31, 2024
8-K Current report
Officer or director change, Shareholder vote results
Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 18, 2024 Nov 14, 2024
144 Notice of proposed sale Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Oct 30, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 30, 2024 Oct 30, 2024
DEF 14A Proxy statement Oct 8, 2024 Nov 21, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
EFFECT Filing May 22, 2024 —
CORRESP Letter to the SEC May 20, 2024 —
UPLOAD Letter from the SEC May 15, 2024 —
4 Insider transaction May 13, 2024 May 10, 2024
S-3 Shelf registration May 9, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
4 Insider transaction Mar 20, 2024 Mar 5, 2024
4 Insider transaction Mar 20, 2024 Mar 5, 2024
4 Insider transaction Mar 20, 2024 Mar 5, 2024
4 Insider transaction Mar 20, 2024 Mar 5, 2024
4 Insider transaction Mar 20, 2024 Mar 5, 2024
4 Insider transaction Mar 20, 2024 Mar 5, 2024
4 Insider transaction Mar 14, 2024 Mar 13, 2024
10-K Annual report Mar 12, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 12, 2024 Mar 12, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
8-K Current report
Other events
Jan 30, 2024 Jan 30, 2024
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
4/A Filing Jan 18, 2024 Jan 12, 2024
4 Insider transaction Jan 17, 2024 Jan 12, 2024
4 Insider transaction Jan 17, 2024 Jan 12, 2024
4 Insider transaction Jan 17, 2024 Jan 12, 2024
4 Insider transaction Jan 17, 2024 Jan 12, 2024
4 Insider transaction Dec 18, 2023 Dec 14, 2023
8-K Current report
Officer or director change
Dec 15, 2023 Dec 12, 2023
4 Insider transaction Dec 14, 2023 Dec 12, 2023
3 Initial insider ownership Dec 14, 2023 Dec 12, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 17, 2023 Nov 16, 2023
8-K Current report
Other events
Nov 16, 2023 Nov 15, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Shareholder vote results
Oct 30, 2023 Oct 26, 2023
ARS Annual report to shareholders Sep 13, 2023 Dec 31, 2022
DEFA14A Additional proxy material Sep 13, 2023 —
DEF 14A Proxy statement Sep 13, 2023 Oct 26, 2023
4 Insider transaction Sep 8, 2023 Sep 8, 2023
8-K Current report
Officer or director change
Aug 17, 2023 Aug 14, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Other events
Jun 30, 2023 Jun 28, 2023
424B5 Prospectus supplement Jun 30, 2023 —
424B5 Prospectus supplement Jun 28, 2023 —
8-K Current report
Other events
Jun 21, 2023 Jun 21, 2023
4 Insider transaction May 19, 2023 May 18, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CRMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Parsippany, NJ
SEC filer status
Non-accelerated filer
SEC CIK
1410098

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.